Methergine (methylergonovine maleate tablets – Lupin, generic) — Cigna
Migraine Headaches – Acute Treatment
Initial criteria
- Patient is age ≥ 18 years; AND
- Patient meets ONE of the following (i or ii):
- i. Patient is already receiving methylergonovine therapy; OR
- ii. Patient meets ALL of the following (a, b, and c):
- a) Patient has tried and had inadequate efficacy and/or unacceptable side effects to at least one triptan therapy; AND
- b) Patient has tried and had inadequate efficacy and/or unacceptable side effects to at least one other type of abortive therapy; AND
- c) The medication is prescribed by or in consultation with a neurologist or headache specialist.
Approval duration
1 year